Memphasys Ltd has released a press release.
MEM Non-Renounceable Rights Issue Offer
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- $400,000 special grant offer from NSW Medical Devices Fund
- $3.75M Capital Raising to Accelerate Dev of Felix Device
- Advanced development of Felix device supported by R&D rebate
- Adjusting amendment to Appendix 4E
- Appendix 4E Preliminary Final Report
Later from Memphasys
- $400,000 Special Grant received from the NSW Medical Devices
- Legal action with Platinum Road / Bridge Road Capital
- Appendix 4D - December 2017 Half year Financial Accounts
- Felix device development update
- Memphasys raises $1m via a strategic investment
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys